Eosinophilic aseptic arachnoiditis. A neurological complication in HIV-negative drug-addicts.

Détails

Ressource 1Télécharger: REF.pdf (407.65 [Ko])
Etat: Public
Version: Final published version
Licence: Non spécifiée
It was possible to publish this article open access thanks to a Swiss National Licence with the publisher.
ID Serval
serval:BIB_682279AC2A27
Type
Article: article d'un périodique ou d'un magazine.
Sous-type
Etude de cas (case report): rapporte une observation et la commente brièvement.
Collection
Publications
Institution
Titre
Eosinophilic aseptic arachnoiditis. A neurological complication in HIV-negative drug-addicts.
Périodique
Journal of neurology
Auteur⸱e⸱s
Rossetti A.O., Meagher-Villemure K., Vingerhoets F., Maeder P., Bogousslavsky J.
ISSN
0340-5354
Statut éditorial
Publié
Date de publication
2002
Peer-reviewed
Oui
Volume
249
Numéro
7
Pages
884-7
Langue
anglais
Notes
Publication types: Case Reports ; Journal Article - Publication Status: ppublish
Résumé
The finding of an eosinophilic aseptic meningitis in IV drug abuse is usually suggestive of an opportunistic infection or an allergic reaction. However, HIV-negative patients are at lower risk for developing these complications. Two young HIV-negative patients, with previous intravenous polytoxicomany, developed cystic arachnoiditis over the spinal cord associated with eosinophilic meningitis. Histology of the meningeal spinal cord lesions revealed a vasculocentric mixed inflammatory reaction. In one patient prednisone led to marked clinical improvement. Since infection, vasculitis, sarcoidosis and previous myelography were ruled out, we believe that the syndrome of eosinophilic aseptic arachnoiditis may be related to an hyperergic reaction in the meniges toward drug-adulterants inoculated through the intravenous route.
Mots-clé
Adult, Anti-Inflammatory Agents, Arachnoiditis, Eosinophilia, Female, Humans, Male, Prednisone, Substance Abuse, Intravenous, Syndrome, Treatment Outcome
Pubmed
Web of science
Open Access
Oui
Création de la notice
11/04/2008 9:23
Dernière modification de la notice
14/02/2022 8:55
Données d'usage